Almokalant
![]() | |
Clinical data | |
---|---|
ATC code | None |
Identifiers | |
| |
CAS Number |
123955-10-2 ![]() |
PubChem (CID) | 3033962 |
ChemSpider |
2298526 ![]() |
UNII |
I9NG89L275 ![]() |
ChEMBL |
CHEMBL362103 ![]() |
Chemical and physical data | |
Formula | C18H28N2O3S |
Molar mass | 352.5 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Almokalant is drug used to treat arrhythmia.[1] It is a potassium channel blocker. It has been found to have teratogenic effects in rats.[2]
References
- ↑ Wiesfeld AC, Crijns HJ, Bergstrand RH, Almgren O, Hillege HL, Lie KI (1993). "Torsades de pointes with Almokalant, a new class III antiarrhythmic drug". American Heart Journal. 126 (4): 1008–1011. doi:10.1016/0002-8703(93)90726-p.
- ↑ Wellfelt, K.; Sköld, A. C.; Wallin, A.; Danielsson, B. R. (1999-04-01). "Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species". Reproductive Toxicology (Elmsford, N.Y.). 13 (2): 93–101. ISSN 0890-6238. PMID 10213516.
This article is issued from Wikipedia - version of the 11/7/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.